Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Start-Up to Manufacture, Supply Practical Radiation Drugs

Radiation

A new company formed by a technology venture investor and the Mayo Clinic aims to produce and supply more readily available radiation drug therapies. . . . → Read More: Start-Up to Manufacture, Supply Practical Radiation Drugs

Drug Licensed for Precision Autism Spectrum Therapies

Brain activity graphic

A company making precision therapies for neurological disorders is acquiring rights to a compound first designed as a treatment for cancer, inflammation, and oxidative stress. . . . → Read More: Drug Licensed for Precision Autism Spectrum Therapies

Nasal Spray Vaccines Get CEPI, NIH Funding

Nasal spray

A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea. . . . → Read More: Nasal Spray Vaccines Get CEPI, NIH Funding

Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test

Malaria clinic

A vaccine grown in genetically-altered algae, designed as a nasal-spray and edible drug, is shown to protect lab mice against parasite infections causing malaria. . . . → Read More: Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test

Start-Up Developing Efficient RNA Process, Raises $12M

Vials and bottles

A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds. . . . → Read More: Start-Up Developing Efficient RNA Process, Raises $12M

Stem Cell Lab Planned for Commercial Space Station

Orbital Reef

A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station. . . . → Read More: Stem Cell Lab Planned for Commercial Space Station

Company Formed to Boost Clinical Trial Success Odds

Human machine interface

A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress. . . . → Read More: Company Formed to Boost Clinical Trial Success Odds

Start-Up Licenses Gene-Edited Drug Discovery Tech.

African clawed frog

A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases. . . . → Read More: Start-Up Licenses Gene-Edited Drug Discovery Tech.

Infographic – Earth Orbits Getting More Crowded

Chart: Increasing space junk

The rate of new earth-orbit launches is accelerating, with OECD expecting tens of thousands of new satellites launched in the next five years. . . . → Read More: Infographic – Earth Orbits Getting More Crowded

NIH Funds Decentralized Rare Disease Data Network

Blockchain

A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency. . . . → Read More: NIH Funds Decentralized Rare Disease Data Network